(MENAFN- GlobeNewsWire - Nasdaq) Thermo Fisher presents market opportunities through digital transformation, innovation programs, and strategic tech initiatives. They leverage partnerships, product launches, and acquisitions across segments like Life Sciences, Analytical Instruments, and Diagnostics, aiding pharmaceuticals, research, and healthcare sectors.

Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Thermo Fisher Scientific - 2025" company profile has been added to ResearchAndMarkets's offering.

The report offers detailed information and insights into Thermo Fisher's technology activities, highlighting its digital transformation strategies and innovation programs. It provides an overview of key technology initiatives, including partnerships, product launches, investments, and acquisitions, along with insights into each initiative's technology theme, objectives, and benefits. Additionally, the report includes details on estimated ICT budgets.
Thermo Fisher Scientific Inc. (Thermo Fisher) is an American company offering a variety of products, solutions and services to the pharmaceuticals, biotechnology, hospitals, and clinical diagnostic labs industries. Its products and services are also widely used by research institutions, government agencies, and universities. Thermo Fisher reports its business performance through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products & Biopharma Services.

The Life Sciences Solutions segment offers reagents, instruments and consumables for customers in pharmaceuticals and medical research industries. The Analytical Instruments segment offers chromatography solutions, electron microscopes, and mass spectrometers. The Specialty Diagnostics segment offers culture media, reagents, diagnostic test kits, and instruments. The Laboratory Products and Biopharma Services segment offers lab consumables, equipment and chemicals. Major brands of the company are Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Labs Services, Patheon, PPD, and Gibco.

Scope

• The report provides insights into the company's tech activities, including its digital transformation strategies, its innovation programs, its technology initiatives, its investments and its acquisitions.

Reasons to Buy

• Gain insights into Thermo Fisher's tech operations.
• Gain insights into its tech strategies and innovation initiatives.
• Gain insights into its technology themes under focus.
• Gain insights into various product launches, partnerships, investments and acquisitions

Key Topics Covered:

• Thermo Fisher's Overview
• Thermo Fisher's Digital Transformation Strategy
• Thermo Fisher's Technology Focus
• Thermo Fisher's Technology Initiatives
• Thermo Fisher's Tech Investments
• Thermo Fisher's Tech Acquisitions
• Thermo Fisher's Tech Ecosystem
• Thermo Fisher's ICT Budget and Contracts
• Thermo Fisher's Senior Management
• Thermo Fisher's Thematic Scorecard

A selection of companies mentioned in this report includes, but is not limited to:

• Mirai Bio
• Evalueserve
• Genoox
• Medidata
• MSAID
• Cellular Origins
• Multiply Labs
• CytoReason
• CorEvitas LLC

For more information about this company profile visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN14112025004107003653ID1110343550